Nutrien (NTR) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

NTR Stock Forecast


Nutrien stock forecast is as follows: an average price target of $72.51 (represents a 54.90% upside from NTR’s last price of $46.81) and a rating consensus of 'Buy', based on 17 wall street analysts offering a 1-year stock forecast.

NTR Price Target


The average price target for Nutrien (NTR) is $72.51 based on 1-year price targets from 17 Wall Street analysts in the past 3 months, with a price target range of $126.00 to $50.00. This represents a potential 54.90% upside from NTR's last price of $46.81.

NTR Analyst Ratings


Buy

According to 17 Wall Street analysts, Nutrien's rating consensus is 'Buy'. The analyst rating breakdown for NTR stock is 0 'Strong Buy' (0.00%), 8 'Buy' (47.06%), 7 'Hold' (41.18%), 2 'Sell' (11.76%), and 0 'Strong Sell' (0.00%).

Nutrien Price Target by Analyst


DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Sep 24, 2024Richard GarchitorenaWells Fargo$50.00$47.485.31%6.81%
Sep 10, 2024Adam SamuelsonGoldman Sachs$53.00$46.0914.99%13.22%
Aug 09, 2024Jacob BoutCIBC$64.00$45.8739.52%36.72%
Aug 09, 2024Joel JacksonBMO Capital$75.00$45.7563.95%60.22%
Aug 08, 2024Edlain RodriguezMizuho Securities$52.00$47.0810.45%11.09%
Jul 15, 2024Andrew WongRBC Capital$60.00$49.6820.77%28.18%
Jun 13, 2024Joel JacksonBMO Capital$80.00$51.1756.34%70.90%
Jun 12, 2024John RobertsUBS$67.00$52.4227.81%43.13%
May 17, 2024Charles NeivertPiper Sandler$56.00$57.48-2.57%19.63%
May 13, 2024Vincent AndersonStifel Nicolaus$69.00$57.3020.42%47.40%
Row per page
Go to

The latest Nutrien stock forecast, released on Sep 24, 2024 by Richard Garchitorena from Wells Fargo, set a price target of $50.00, which represents a 5.31% increase from the stock price at the time of the forecast ($47.48), and a 6.81% increase from NTR last price ($46.81).

Nutrien Price Target by Period


1M3M12M
# Anlaysts-215
Avg Price Target-$51.50$63.47
Last Closing Price$46.81$46.81$46.81
Upside/Downside-100.00%10.02%35.59%

In the current month, the average price target of Nutrien stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Nutrien's last price of $46.81. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades


DateCompanyPrevious RatingNew RatingRating Change
Oct 15, 2024JefferiesBuyBuyHold
Sep 24, 2024Wells FargoOverweightEqual-WeightDowngrade
Sep 10, 2024Goldman Sachs-NeutralDowngrade
Aug 09, 2024CIBCOutperformOutperformHold
Aug 09, 2024BMO CapitalOutperformOutperformHold
Aug 01, 2024HSBCHoldReduceDowngrade
Jul 15, 2024RBC CapitalOutperformOutperformHold
Jun 13, 2024ScotiabankSector OutperformSector OutperformHold
Jun 13, 2024BMO CapitalOutperformOutperformHold
Jun 12, 2024UBSBuyBuyHold
Row per page
Go to

Nutrien's last stock rating was published by Jefferies on Oct 15, 2024. The company gave NTR a "Buy" rating, the same as its previous rate.

Nutrien Financial Forecast


Nutrien Revenue Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Revenue------------$5.82B--$6.11B$7.53B$8.19B$14.51B$7.66B$7.27B$6.02B$9.76B$4.66B$4.10B$4.21B$8.42B$4.19B$3.54B$4.13B
Avg Forecast$5.34B$5.02B$9.95B$5.13B$5.35B$5.24B$10.12B$5.13B$5.08B$5.33B$10.82B$5.29B$5.49B$5.72B$11.06B$6.36B$7.41B$8.53B$14.68B$7.65B$6.47B$5.41B$9.66B$4.44B$3.56B$3.76B$8.34B$3.54B$3.48B$4.04B
High Forecast$5.48B$5.15B$10.21B$5.26B$5.49B$5.38B$10.39B$5.16B$5.17B$5.47B$11.10B$5.43B$5.72B$6.21B$11.35B$6.53B$7.60B$8.53B$14.68B$7.65B$6.47B$5.41B$9.66B$4.44B$3.56B$3.76B$8.34B$3.54B$3.48B$4.04B
Low Forecast$5.17B$4.86B$9.64B$4.97B$5.18B$5.08B$9.81B$5.10B$4.93B$5.16B$10.48B$5.12B$5.26B$5.39B$10.72B$6.16B$7.18B$8.53B$14.68B$7.65B$6.47B$5.41B$9.66B$4.44B$3.56B$3.76B$8.34B$3.54B$3.48B$4.04B
# Analysts1111111254336109988889999999955
Surprise %------------1.06%--0.96%1.02%0.96%0.99%1.00%1.12%1.11%1.01%1.05%1.15%1.12%1.01%1.18%1.02%1.02%

Nutrien's average Quarter revenue forecast for Mar 24 based on 3 analysts is $5.29B, with a low forecast of $5.12B, and a high forecast of $5.43B. NTR's average Quarter revenue forecast represents a -9.14% decrease compared to the company's last Quarter revenue of $5.82B (Dec 23).

Nutrien EBITDA Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts1111111254336109988889999999955
EBITDA------------$1.27B--$1.42B$2.15B$2.43B$5.06B$2.48B$2.19B$1.54B$2.10B$752.00M$870.00M$-222.00M$1.66B$555.00M$450.00M$785.00M
Avg Forecast$1.22B$1.15B$2.28B$1.17B$1.22B$1.20B$2.31B$1.17B$1.16B$1.22B$2.47B$3.00B$1.25B$1.31B$2.53B$2.73B$2.01B$1.95B$3.36B$2.48B$1.48B$1.24B$2.21B$919.11M$813.44M$859.28M$1.91B$244.20M$795.12M$923.90M
High Forecast$1.25B$1.18B$2.34B$1.20B$1.26B$1.23B$2.38B$1.18B$1.18B$1.25B$2.54B$3.60B$1.31B$1.42B$2.60B$3.27B$2.41B$1.95B$3.36B$2.98B$1.48B$1.24B$2.21B$1.10B$813.44M$859.28M$1.91B$293.04M$795.12M$923.90M
Low Forecast$1.18B$1.11B$2.20B$1.14B$1.19B$1.16B$2.24B$1.17B$1.13B$1.18B$2.40B$2.40B$1.20B$1.23B$2.45B$2.18B$1.61B$1.95B$3.36B$1.98B$1.48B$1.24B$2.21B$735.29M$813.44M$859.28M$1.91B$195.36M$795.12M$923.90M
Surprise %------------1.02%--0.52%1.07%1.25%1.51%1.00%1.48%1.24%0.95%0.82%1.07%-0.26%0.87%2.27%0.57%0.85%

3 analysts predict NTR's average Quarter EBITDA for Mar 24 to be $3.00B, with a high of $3.60B and a low of $2.40B. This is 135.68% upper than Nutrien's previous annual EBITDA (Dec 23) of $1.27B.

Nutrien Net Income Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts1111111254336109988889999999955
Net Income------------$172.00M--$571.00M$1.11B$1.58B$3.59B$1.38B$1.21B$717.00M$1.11B$127.00M$316.00M$-587.00M$765.00M$-35.00M$-48.00M$141.00M
Avg Forecast$272.55M$149.63M$1.02B$232.23M$351.33M$279.32M$1.06B$179.98M$197.00M$228.69M$1.08B$1.69B$318.71M$303.97M$1.37B$1.53B$1.04B$1.91B$2.83B$1.39B$1.18B$602.32M$1.04B$155.22M$86.51M$58.25M$656.59M$-15.40M$120.41M$197.62M
High Forecast$281.87M$154.75M$1.05B$240.17M$363.34M$288.87M$1.10B$199.98M$248.21M$236.51M$1.09B$2.02B$442.65M$442.54M$1.41B$1.84B$1.25B$1.91B$2.83B$1.67B$1.18B$609.32M$1.04B$186.27M$86.51M$58.25M$656.59M$-12.32M$120.41M$197.62M
Low Forecast$261.52M$143.58M$976.93M$222.84M$337.12M$268.02M$1.02B$144.98M$94.56M$219.44M$1.08B$1.35B$212.47M$219.03M$1.31B$1.23B$831.95M$1.91B$2.83B$1.11B$1.18B$595.31M$1.04B$124.18M$86.51M$58.25M$656.59M$-18.48M$120.41M$197.62M
Surprise %------------0.54%--0.37%1.07%0.83%1.27%0.99%1.02%1.19%1.06%0.82%3.65%-10.08%1.17%2.27%-0.40%0.71%

Nutrien's average Quarter net income forecast for Mar 24 is $1.69B, with a range of $1.35B to $2.02B. NTR's average Quarter net income forecast represents a 880.06% increase compared to the company's last Quarter net income of $172.00M (Dec 23).

Nutrien SG&A Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts1111111254336109988889999999955
SG&A------------$1.04B--$930.00M$970.00M$1.00B$1.10B$988.00M$1.08B$923.00M$1.02B$799.00M$909.00M$812.00M$876.00M$714.00M$796.00M$683.00M
Avg Forecast$712.23M$669.44M$1.33B$683.91M$713.95M$699.35M$1.35B$684.60M$677.58M$711.07M$1.44B$1.21B$731.89M$762.62M$1.48B$1.10B$931.70M$1.14B$1.96B$998.86M$863.38M$722.34M$1.29B$976.56M$474.61M$501.36M$1.11B$314.16M$463.92M$539.06M
High Forecast$730.96M$687.05M$1.36B$701.90M$732.72M$717.74M$1.39B$688.45M$690.39M$729.77M$1.48B$1.45B$762.62M$828.31M$1.51B$1.32B$1.12B$1.14B$1.96B$1.20B$863.38M$722.34M$1.29B$1.17B$474.61M$501.36M$1.11B$376.99M$463.92M$539.06M
Low Forecast$690.07M$648.61M$1.29B$662.63M$691.73M$677.59M$1.31B$680.74M$658.37M$688.95M$1.40B$966.89M$701.16M$718.66M$1.43B$878.99M$745.36M$1.14B$1.96B$799.09M$863.38M$722.34M$1.29B$781.24M$474.61M$501.36M$1.11B$251.33M$463.92M$539.06M
Surprise %------------1.43%--0.85%1.04%0.88%0.56%0.99%1.25%1.28%0.79%0.82%1.92%1.62%0.79%2.27%1.72%1.27%

Nutrien's average Quarter SG&A projection for Mar 24 is $1.21B, based on 3 Wall Street analysts, with a range of $966.89M to $1.45B. The forecast indicates a 15.87% rise compared to NTR last annual SG&A of $1.04B (Dec 23).

Nutrien EPS Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts1111111254336109988889999999955
EPS------------$0.36--$1.14$2.15$2.95$6.53$2.49$2.12$1.26$1.94$0.22$0.55$-1.03$1.34$-0.06$-0.08$0.25
Avg Forecast$0.55$0.30$2.06$0.47$0.71$0.56$2.15$0.36$0.40$0.46$2.19$0.38$0.64$0.61$2.76$1.48$2.54$3.85$5.71$2.76$2.38$1.22$2.11$0.08$0.17$0.12$1.33$-0.04$0.24$0.40
High Forecast$0.57$0.31$2.13$0.49$0.73$0.58$2.22$0.40$0.50$0.48$2.20$0.38$0.89$0.89$2.86$1.50$2.63$3.85$5.71$2.76$2.38$1.23$2.11$0.08$0.17$0.12$1.33$-0.04$0.24$0.40
Low Forecast$0.53$0.29$1.97$0.45$0.68$0.54$2.06$0.29$0.19$0.44$2.18$0.38$0.43$0.44$2.65$1.45$2.44$3.85$5.71$2.76$2.38$1.20$2.11$0.08$0.17$0.12$1.33$-0.04$0.24$0.40
Surprise %------------0.56%--0.77%0.85%0.77%1.14%0.90%0.89%1.04%0.92%2.65%3.15%-8.75%1.01%1.48%-0.34%0.63%

According to 3 Wall Street analysts, Nutrien's projected average Quarter EPS for Mar 24 is $0.38, with a low estimate of $0.38 and a high estimate of $0.38. This represents a 6.11% increase compared to NTR previous annual EPS of $0.36 (Dec 23).

Nutrien Peer Comparison by Price Target


TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
AVDAmerican Vanguard$6.43$20.00211.04%Buy
FMCFMC$55.73$92.5666.09%Buy
ICLICL Group$4.30$7.0764.42%Hold
NTRNutrien$46.81$72.5154.90%Buy
MOSMosaic Company$26.12$39.6751.88%Buy
CFCF Industries$85.21$103.1121.01%Buy
CTVACorteva$57.66$66.9516.11%Buy
IPIIntrepid Potash$27.40$31.5014.96%Hold
SMGScotts Miracle-Gro Company$72.83$80.1710.08%Hold

NTR Forecast FAQ


Is Nutrien a good buy?

Yes, according to 17 Wall Street analysts, Nutrien (NTR) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 8 'Buy' recommendations, accounting for 47.06% of NTR's total ratings.

What is NTR's price target?

Nutrien (NTR) average price target is $72.51 with a range of $50 to $126, implying a 54.90% from its last price of $46.81. The data is based on 17 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Nutrien stock go up soon?

According to Wall Street analysts' prediction for NTR stock, the company can go up by 54.90% (from the last price of $46.81 to the average price target of $72.51), up by 169.17% based on the highest stock price target, and up by 6.81% based on the lowest stock price target.

Can Nutrien stock reach $70?

NTR's average twelve months analyst stock price target of $72.51 supports the claim that Nutrien can reach $70 in the near future.

What are Nutrien's analysts' financial forecasts?

Nutrien's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $25.85B (high $26.42B, low $25.17B), average EBITDA is $5.91B (high $6.04B, low $5.76B), average net income is $1.87B (high $1.95B, low $1.77B), average SG&A $3.45B (high $3.52B, low $3.36B), and average EPS is $3.79 (high $3.95, low $3.58). NTR's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $25.43B (high $26.1B, low $24.64B), average EBITDA is $5.82B (high $5.97B, low $5.63B), average net income is $1.67B (high $1.73B, low $1.6B), average SG&A $3.39B (high $3.48B, low $3.29B), and average EPS is $3.38 (high $3.49, low $3.24).

Did the NTR's actual financial results beat the analysts' financial forecasts?

Based on Nutrien's last annual report (Dec 2022), the company's revenue was $37.88B, which missed the average analysts forecast of $38.27B by -1.01%. Apple's EBITDA was $12.07B, beating the average prediction of $9.79B by 23.22%. The company's net income was $7.66B, beating the average estimation of $7.17B by 6.90%. Apple's SG&A was $4.07B, missing the average forecast of $5.03B by -19.03%. Lastly, the company's EPS was $13.45, missing the average prediction of $14.87 by -9.52%. In terms of the last quarterly report (Dec 2023), Nutrien's revenue was $5.82B, beating the average analysts' forecast of $5.49B by 6.10%. The company's EBITDA was $1.27B, beating the average prediction of $1.25B by 1.50%. Nutrien's net income was $172M, missing the average estimation of $318.71M by -46.03%. The company's SG&A was $1.04B, beating the average forecast of $731.89M by 42.51%. Lastly, the company's EPS was $0.36, missing the average prediction of $0.644 by -44.10%